Multiple Myeloma Treatment Options | First Line Therapy
Cancers | Free Full-Text | 30 Years of Improved Survival in Non-Transplant-Eligible Newly Diagnosed Multiple Myeloma
Expert Guidance on Current Standards and New Directions in Newly Diagnosed Multiple Myeloma
The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple My
VA Committee
Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone. - Abstract - Europe PMC
Cancers | Free Full-Text | Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies
Role of Anti–CD38 Antibody Therapy in Induction and Maintenance in Newly Diagnosed Multiple Myeloma: How to Adopt in Clinical Practice
Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review - McCaughan - 2022 - British Journal of Haematology - Wiley Online Library
Treatment Considerations for Transplant-Ineligible Multiple Myeloma
Patient characteristics associated with dose modifications for VRd among newly diagnosed multiple myeloma patients | Future Oncology
The efficacy and safety of modified bortezomib‐lenalidomide‐dexamethasone in transplant‐eligible patients with newly diagnosed multiple myeloma - Okazuka - 2020 - European Journal of Haematology - Wiley Online Library
Patient Case 3: Transplant-Ineligible Newly Diagnosed Multiple Myeloma
Multiple Myeloma Tumor Board: Maintenance, Consolidation, and Continuous Therapy (Transcript)
Final Thoughts on Case Study and Treating Multiple Myeloma
Designing a Therapy Sequence for the Treatment of Multiple Myeloma
Pharmaceuticals | Free Full-Text | The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
Combination Regimens for Multiple Myeloma Show Efficacy in the Transplant-Ineligible Population, According to Dingli
Mohamad Mohty on Twitter: "VRD lite is a key player in my opinion @Mohty_EBMT #ASH17 https://t.co/eHqUTtQwMU" / Twitter
Current approaches to management of newly diagnosed multiple myeloma - Goel - 2022 - American Journal of Hematology - Wiley Online Library
Developments in Newly Diagnosed Multiple Myeloma: Considerations for Improved Patient Outcomes
